Central nervous system progression of metastatic breast cancer in patients treated with paclitaxel

Bone Marrow Transplant

2001 • 3,479 citations

Taxol: A Unique Antineoplastic Agent with Significant Activity in Advanced Ovarian Epithelial Neoplasms

1989 • 1,111 citations

Central nervous system metastasis from breast carcinoma autopsy study

1983 • 1,051 citations

THE IMPACT OF NATIONAL CANCER ACT

1991 • 809 citations

Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast Cancer

1991 • 730 citations

Intracranial metastases from systemic cancer.

1978 • 621 citations

Taxol: an antimitotic agent with a new mechanism of action

1984 • 483 citations

Phase II Study of Taxol in Patients With Untreated Advanced Non-Small-Cell Lung Cancer

1993 • 441 citations

Drug delivery to the central nervous system: A review

1992 • 371 citations

Phase II Study of Taxol, Merbarone, and Piroxantrone in Stage IV Non-Small-Cell Lung Cancer: The Eastern Cooperative Oncology Group Results

1993 • 346 citations

Chemotherapy induces regression of brain metastases in breast carcinoma

1986 • 271 citations

Paclitaxel and recombinant human granulocyte colony-stimulating factor as initial chemotherapy for metastatic breast cancer.

1993 • 244 citations

Response of brain metastases from breast cancer to systemic chemotherapy

1992 • 235 citations

Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: a phase I/II trial of 96-hour infusion.

1994 • 221 citations

Paclitaxel as second and subsequent therapy for metastatic breast cancer: activity independent of prior anthracycline response.

1995 • 208 citations

A phase II trial of taxol in metastatic melanoma

1990 • 175 citations

Taxol in advanced, hormone-refractory carcinoma of the prostate. A phase II trial of the eastern cooperative oncology group

1993 • 163 citations

Phase II evaluation of Taxol in advanced head and neck cancer: an Eastern Cooperative Oncology group trial.

1993 • 91 citations

Complete Remissions in Metastatic Breast Cancer Treated with Combination Drug Therapy

1979 • 90 citations

Brain metastases in breast cancer patients receiving adjuvant chemotherapy

1982 • 74 citations

Technique to Improve the Rate of Healing of Incised Abscesses

1972 • 68 citations

Treatment of Acute Lymphoblastic Leukaemia: Effect of "Prophylactic" Radiotherapy against Central Nervous System Leukaemia: REPORT TO THE MEDICAL RESEARCH COUNCIL BY THE LEUKAEMIA COMMITTEE AND THE WORKING PARTY ON LEUKAEMIA IN CHILDHOOD

1973 • 64 citations

Phase II trial of taxol in patients with adenocarcinoma of the upper gastrointestinal tract (UGIT)

1995 • 44 citations

Combination chemotherapy and systemic irradiation consolidation for poor prognosis breast cancer

1987 • 27 citations

Survival After Phase II Treatment of Advanced Renal Cell Carcinoma with Taxol or High-Dose Interleukin-2

1993 • 21 citations

Adriamycin and 1-(2-Chlorethyl)-3-Cyclohexyl-1-Nitrosourea (CCNU) in the treatment of metastatic breast cancer

1978 • 18 citations

Combination chemotherapy and high-dose cyclophosphamide intensification for poor prognosis breast cancer. A southwest oncology group study

1989 • 14 citations

Isolated/primary CNS relapse in women in remission after ABMT for metastatic breast cancer.

1992 • 11 citations

Proceedings of the second National Cancer Institute workshop on taxol and taxus : held at Alexandria, Virginia, September 23-24, 1992

1993 • 7 citations

Aggressive doxorubicin-containing regimen (prednisone, methotrexate, 5-FU, doxorubicin, and cyclophosphamide; PM-FAC) in disseminated estrogen receptor-negative breast cancer.

1984 • 3 citations